ACS IRG Grants: Cancer Disparities Research
Grant to Focus on Cancer Disparities Research by Junior Investigators
This is the 14th year of an American Cancer Society Institutional Research Grant (ACS IRG) that was awarded to the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) to support promising new research by junior faculty members. The ACS Institutional Research Grant provides seed money to new investigators without a national competitive research grant, so that they can obtain preliminary results that will enable them to compete successfully for national research grants.
The principal investigator of the IRG is Stuart S. Martin, Ph.D., Professor of Physiology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine.
The Spring deadline for the ACS-IRG applications is May 1st, 2019 by 4:00pm.
Only junior level faculty members are eligible for the ACS IRG. Junior investigators are faculty within 6 years of their first independent faculty appointment or equivalent (e.g., Instructor, Assistant Professor, and Research Assistant Professor). Investigators who have already received a peer-reviewed national research grant are not eligible to apply. NIH Career Development (K) awards do not count as peer-reviewed national research grants for this purpose. Investigators who have received prior support from the ACS Institutional Research Grant are not eligible.
Non-faculty (e.g., residents, fellows) are not eligible.
New Rule as of 2018: The ACS has changed the eligibility requirements. US citizenship is no longer a requirement. However, if not a US Citizen, the applicant must have a VISA that will cover the time requirement to complete his/her project. Applicants who are not U.S. citizens are now welcome to apply.
New for 2017 Funding: UMGCCC will be funding three projects this year at $30,000 each. At least one Cancer Disparities pilot project will receive an award, and Cancer-Related and Cancer Disparities projects will be competing together for the third award.
Please submit the signed and hard copy and an electronic copy to:
Marlene and Stewart Greenebaum Comprehensive Cancer Center
655 W. Baltimore Street
Room 9-002, Bressler Research Building
Baltimore, MD 21201
The pilot project grant applications will be reviewed by the local Institutional Research Grant Committee chaired by Dr. Martin. The committee is composed of UMB faculty and a representative of the ACS Mid-Atlantic Division.
For More Information